Cover Image

Bempedoic Acid in Secondary Prevention

Saved in:

Bibliographic Details
Main Authors:	Idine Mousavi (Author), Vijay Nambi (Author), Layla A. Abushamat (Author), Sadeer G. Al-Kindi (Author), Michael D. Shapiro (Author), Laurence Sperling (Author), Salim S. Virani (Author), Abdul Mannan Khan Minhas (Author)
Format:	Book
Published:	Elsevier, 2024-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bempedoic acid for the treatment of dyslipidemia
by: Joel C Marrs, et al.
Published: (2020)

The Pathogenetic Basis of the Action of Bempedoic Acid
by: A. S. Petrosyan, et al.
Published: (2023)

Pharmacokinetics of bempedoic acid in patients with renal impairment
by: Benny M. Amore, et al.
Published: (2022)

Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside
by: Agarwala A, et al.
Published: (2021)

Bempedoic acid - new agent in hiperlipidemia treatment - literature review
by: Agata Frańczuk, et al.
Published: (2024)

SOCIAL VULNERABILITY AND CARDIOVASCULAR DISEASE-RELATED MORTALITY IN OLDER ADULT, 2016-2020
by: Abdul Mannan Khan Minhas, MD, et al.
Published: (2023)

INTERSECTION OF RACE, INCOME AND CARDIOVASCULAR DISEASES IN THE UNITED STATES
by: Abdul Mannan Khan Minhas, MD, et al.
Published: (2023)

Bempedoic Acid: Safety and Efficiacy of a New Lipid-Lowering Agent
by: I. A. Mazerkina, et al.
Published: (2023)

Bempedoic Acid: A Novel Approach in Managing Dyslipidemia and Reducing Cardiovascular Risk
by: Łukasz Wołowiec, et al.
Published: (2024)

Bempedoic Acid and Statins in Lipid-Lowering Strategy: Which Came First, the Egg or the Chicken?
by: Francesco Natale, et al.
Published: (2023)

Mechanism of bempedoic acid induced cholelithiasis: A role for statins to limit this adverse effect?
by: Nicola Ferri, et al.
Published: (2023)

Stability indicating RP-UPLC method for simultaneous quantification of bempedoic acid and ezetimibe in bulk and pharmaceutical formulations
by: Uma Sai Teja Yarra, et al.
Published: (2021)

Physiologically Based Pharmacokinetic Model Development and Verification for Bioequivalence Testing of Bempedoic Acid Oral Suspension and Reference Tablet Formulation
by: Benny M. Amore, et al.
Published: (2023)

Absence of effect of steady state bempedoic acid on cardiac repolarization: Results of a thorough QT/QTc study in healthy volunteers
by: Benny M. Amore, et al.
Published: (2021)

Bempedoic Acid, the First-in-Class Oral ATP Citrate Lyase Inhibitor with Hypocholesterolemic Activity: Clinical Pharmacology and Drug-Drug Interactions
by: Nicola Ferri, et al.
Published: (2024)

A UK multicentre audit of the management of patients with primary hypercholesterolaemia or mixed dyslipidaemia with bempedoic acid against published lipid-lowering treatment targets
by: Sudarshan Ramachandran, et al.
Published: (2024)

Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials
by: Xiang Zhao, et al.
Published: (2020)

Characterization of novel stress degradation products of Bempedoic acid and Ezetimibe using UPLC-MS/MS: development and validation of stability-indicating UPLC method
by: Anuradha Vejendla, et al.
Published: (2021)

Effect of bempedoic acid plus ezetimibe fixed-dose combination vs ezetimibe or placebo on low-density lipoprotein cholesterol in patients with type 2 diabetes and hypercholesterolemia not treated with statins
by: Harold E. Bays, et al.
Published: (2021)

ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF STROKE
by: P. S. Laguta
Published: (2017)

Lifelong prevention of atherosclerotic cardiovascular disease (ASCVD) through LDL-C control - Means and cost/benefit of sustained very low lifetime LDL-C targets
by: Mayank Dalakoti, et al.
Published: (2024)

CLINICIANS' SELF-REPORTED EFFICACY IN CARDIOVASCULAR PREVENTION PRACTICE IN THE SOUTHEASTERN UNITED STATES
by: Trevor Caldarera, et al.
Published: (2023)

IMPLEMENTATION OF SPECIALTY CLINICAL PHARMACIST IN A PREVENTIVE CARDIOLOGY CLINIC
by: Justin Joy, et al.
Published: (2023)

AN OBSERVATIONAL ANALYSIS OF 7,000 PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA: IDENTIFYING AN AGE-TREATMENT GAP IN CARDIOVASCULAR RISK REDUCTION
by: Elizabeth Jean-Marie, et al.
Published: (2023)

ATP citrate lyase inhibitor Bempedoic Acid alleviate long term HFD induced NASH through improvement in glycemic control, reduction of hepatic triglycerides & total cholesterol, modulation of inflammatory & fibrotic genes and improvement in NAS score
by: K.V. Sanjay, et al.
Published: (2021)

EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: S. N. Tolpygina, et al.
Published: (2015)

ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
by: N. A. Dmitrieva, et al.
Published: (2016)

EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: S. N. Tolpygina, et al.
Published: (2015)

ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS
by: N. A. Dmitrieva, et al.
Published: (2016)

Association of Anisocytosis with Markers of Immune Activation and Exhaustion in Treated HIV
by: Sadeer G. Al-Kindi, et al.
Published: (2017)

NEW EVIDENCES OF POSSIBILITY OF OMEGA-3 ACIDS USE FOR MYOCARDIAL INFARCTION SECONDARY PREVENTION
by: A. I. Martinov, et al.
Published: (2016)

An ode to valproic acid: A letter to the editor
by: Anna P. Shapiro-Krew, et al.
Published: (2024)

Properties of Polyunsaturated Fatty Acids in Primary and Secondary Prevention of Cardiovascular Diseases in the View of Patients (Silesia, Poland)
by: Karolina Krupa-Kotara, et al.
Published: (2022)

Secondary prevention of hidradenitis suppurativa
by: Hjalmar Kurzen, et al.
Published: (2019)

Non-ST elevation myocardial infarction secondary to carbon monoxide intoxication
by: Danuta Jankowska, et al.
Published: (2017)

Knowledge, attitude and practice of diabetes among secondary school-going children in Bangladesh
by: Farhana Akter, et al.
Published: (2022)

The projected impact of the inflation reduction act's climate provisions on cardiovascular and respiratory outcomes
by: Ashish Kumar, et al.
Published: (2024)

Soluble Tumor Necrosis Factor Receptor 1 is Associated With Cardiovascular Risk in Persons With Coronary Artery Calcium Score of Zero
by: Tony Dong, et al.
Published: (2021)

WHF Roadmap on Secondary Prevention of CVD
by: David A. Wood
Published: (2024)

Mobile health for the secondary prevention of stroke
by: Yogeshwar Kalkonde, et al.
Published: (2023)